BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3197595)

  • 1. [Protective effects of lidoflazine and mioflazine in ischemic myocardium].
    Liu GS; Borgers M; Xhonneux R
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):100-2, 127. PubMed ID: 3197595
    [No Abstract]   [Full Text] [Related]  

  • 2. Myocardial protection by lidoflazine during one-hour normothermic global ischemia.
    Daenen W; Flameng W
    Angiology; 1981 Aug; 32(8):543-51. PubMed ID: 7258731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary prevention of ischemic heart disease: a long-term controlled lidoflazine study.
    De Geest H; Kesteloot H; Piessens J
    Acta Cardiol Suppl; 1979; (24):7-116. PubMed ID: 122040
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of lidoflazin in the treatment of ischemic heart disease].
    Fomina AA; Mironova KA; Glomozda NIa; Klimovich MD
    Vrach Delo; 1977 Mar; (3):68-71. PubMed ID: 855300
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation and use of the coronary and anti-arrhythmic drug Lidoflazin. Clinical, electrocardiographic, hemodynamic, and laboratory-chemical studies on 187 patients].
    Lehmann HU; Ghabussi P; Hochrein H
    Med Welt; 1977 Feb; 28(8):386-90. PubMed ID: 321914
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ambulatory treatment experience with lidoflazine in ischemic heart disease].
    Pmerantsev VP; Ivanova NA; Zadionchenko VS; Vertkin AL; Martynov AI
    Kardiologiia; 1980 Jul; 20(7):109-10. PubMed ID: 7401433
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lidoflazine and dysrhythmia (author's transl)].
    Bergouignan J; Lefebvre D; Levol B; Ory J
    Ann Cardiol Angeiol (Paris); 1976; 25(2):155-60. PubMed ID: 1267401
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardioprotective effects of lidoflazine during 1-hour normothermic global ischemia.
    Flameng W; Daenen W; Borgers M; Thone F; Xhonneux R; van de Water A; van Belle H
    Circulation; 1981 Oct; 64(4):796-807. PubMed ID: 7273379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathophysiology of angina pectoris and the effect of lidoflazine.
    Gobel FL; Nordstrom LA; Nelson RR; Wang Y
    Circulation; 1982 Jan; 65(1 Pt 2):I27-32. PubMed ID: 7030519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-homogenous irrigation of the myocardium and its importance in cardiac therapeutics].
    Schaper W
    Brux Med; 1973 Sep; 53(9):523-7. PubMed ID: 4202038
    [No Abstract]   [Full Text] [Related]  

  • 11. Pretreatment with lidoflazine, a calcium-channel blocker. Useful adjunct to heterogeneous cold potassium cardioplegia.
    Kates RA; Dorsey LM; Kaplan JA; Hatcher CR; Guyton RA
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):278-86. PubMed ID: 6823146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effects of lidoflazine in extensive aorta-coronary bypass grafting.
    Flameng W; Borgers M; Van der Vusse GJ; Demeyere R; Vandermeersch E; Thoné F; Suy R
    J Thorac Cardiovasc Surg; 1983 May; 85(5):758-68. PubMed ID: 6601746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and ergometric studies on the effectiveness of lidoflazine in the treatment of chronic ischemic heart disease].
    Teichmann W; Vogel HC; Schäbitz J; Schmeisser M; Lukesch KH
    Z Gesamte Inn Med; 1976 Mar; 31(6):161-6. PubMed ID: 941465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Controlled study oflidoflazine in ischemic heart disease].
    Demin AA; Balashov VA
    Kardiologiia; 1977 Dec; 17(12):125. PubMed ID: 340757
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinium used in the treatment of chronic ischaemic cardiac failures.
    Teichmann W; Schäbitz J; Schmeisser M; Vogel H; Lukesch K
    Ther Hung; 1975; 23(2):43-9. PubMed ID: 810909
    [No Abstract]   [Full Text] [Related]  

  • 16. [Non-invasive examination of cardiac hemodynamics in an anginal coronary syndrome after long term treatment with lidoflazine].
    Dvorák I; Zemánková J; Bravený P; Blaha M; Dvorák M; Sedá L; Havlát F
    Vnitr Lek; 1981 Apr; 27(4):338-44. PubMed ID: 7027603
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of lidoflazine on ventricular ectopic activity in chronic ischaemic heart disease.
    Myburgh DP
    S Afr Med J; 1975 Nov; 49(50):2087-90. PubMed ID: 1198246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mioflazine, a potentially protective drug against ischaemic damage: a study in dogs.
    Wood AJ; Isted K; Hynd J; Main MJ; Noble MI; Parker J; Drake-Holland AJ
    Eur Heart J; 1985 Aug; 6(8):695-701. PubMed ID: 4054139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of lidoflazine in angina pectoris. A long-term double-blind study].
    Lehmann H; Hochrein H
    Med Klin; 1976 Jan; 71(5):189-96. PubMed ID: 814396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lidoflazine does not improve neurologic outcome when administered after complete cerebral ischemia in primates.
    Fleischer JE; Lanier WL; Milde JH; Michenfelder JD
    J Cereb Blood Flow Metab; 1987 Jun; 7(3):366-71. PubMed ID: 3584269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.